The Year in Medicaid 2024
In this look back at the events of 2024, we recap significant events that shaped Medicaid pharmacy practice.
Read More
What the Medicaid Rebate Final Rule Means for Manufacturers
On November 19, 2024, the 2024 Medicaid Rebate Final Rule went into effect. The Final Rule establishes new oversight and enforcement measures for the Medicaid Drug Rebate Program (MDRP), primarily based on the changes introduced by the Medicaid Services Investment and Accountability Act of 2019 (MSIAA).
Read More
Register for Crossroads 2025
Registration for Crossroads 2025 is officially open. Crossroads will be held on August 25-27, 2025, in Nashville, Tennessee.
Read More
Changes to New York’s Rebate Programs
Manufacturers are often intimidated when directed by New York to participate in Medicaid, due to the uniqueness of their programs. We aim to eliminate confusion in navigating these processes to resolution. In this blog post, we’ll walk you through a summary of the most recent changes to the New York Medicaid programs.
Read More
State Medicaid Programs Retake Pharmacy Controls
State Medicaid programs’ relationships with managed care organizations that serve Medicaid recipients continue to evolve. Just when it appears that trends are slowing or stabilizing, a new method is introduced. The latest development could overlap existing state controls to bring even more pharmacy control back to state management.
Read More
Reimbursement Challenges with High-Cost Inpatient Drugs
The management and reimbursement of inpatient drug costs in Medicaid programs are pivotal topics, especially with the proliferation of high-cost therapies. The emergence of expensive inpatient drugs, such as cell and gene therapies, have challenged Diagnosis Related Groups (DRGs), the traditional bundled payment system used by hospitals.
Read More